Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
05/2003
05/21/2003EP1311542A2 Peptide selection method
05/21/2003EP1311541A1 IMMUNOGENIC PROTEINS DERIVED FROM DOMESTIC MITE ALLERGEN, BLOMIA TROPICALIS (Bt5)
05/21/2003EP1311540A2 Altered ospa of borrelia burgdorferi
05/21/2003EP1311539A2 Pro-apoptotic fragments of the dengue virus envelope glycoproteins
05/21/2003EP1311538A2 Inhibitors of hiv replication and method of treatment of hiv infections
05/21/2003EP1311537A2 Identification of a cam-kinase ii inhibitor
05/21/2003EP1311529A1 Novel tumor suppressor encoding nucleic acid, ptx1, and methods of use thereof
05/21/2003EP1311297A1 A method for reducing stress-induced overproduction of neuropeptide y in an individual
05/21/2003EP1311292A2 Vitronectin receptor antagonist pharmaceuticals
05/21/2003EP1311290A2 Expression of herstatin, an alternative her-2/neu product, in cells that express either p185her-2 or the egf receptor inhibits receptor activity and cell growth
05/21/2003EP1311289A2 Vaccines containing ribavirin and methods of use thereof
05/21/2003EP1311285A2 Liquid pharmaceutical composition containing an erythropoietin derivative
05/21/2003EP1311283A2 Omega-conopeptides
05/21/2003EP1311282A1 High affinity integrin polypeptides and uses thereof
05/21/2003EP1311280A2 Cell internalized peptide-drug conjugates
05/21/2003EP1311163A2 Improved insecticidal bacteria, and methods for making and using them
05/21/2003EP1311162A2 Bacillus thurigiensis crystal protein hybrids
05/21/2003EP1218399A4 Cacna1g polynucleotide, polypeptide and methods of use therefor
05/21/2003EP1140976A4 Secreted proteins and uses thereof
05/21/2003EP1082463A4 Mechanical stress induced genes, expression products therefrom, and uses thereof
05/21/2003EP1015593B1 Hepatitis b virus polypeptides
05/21/2003EP0923306B1 Frozen food with antifreeze peptides
05/21/2003EP0879383B1 Bioluminescent novelty items
05/21/2003EP0877752B1 Methods for screening for transdominant effector peptides and rna molecules
05/21/2003EP0820285B1 Methods and compositions for lipidization of hydrophilic molecules
05/21/2003EP0765166B1 Radiolabeled annexin-galactose conjugates
05/21/2003EP0720618B1 Process for the purification of basic fibroblast growth factor
05/21/2003EP0707650B1 Process for producing human relaxin
05/21/2003EP0633931B1 Monoclonal antibodies against the interferon receptor, with neutralizing activity against type i interferon
05/21/2003EP0575545B1 Pegylation of polypeptides
05/21/2003EP0573551B1 Serine-rich peptide linkers
05/21/2003EP0411031B1 THE HUMAN C3b/C4b RECEPTOR (CR1)
05/21/2003CN1419605A Method of concentrating and recovering a viral enzyme activity from biological samples
05/21/2003CN1419603A Inhibitors of apoptosis
05/21/2003CN1419602A Precursors of silk-like materials, silk-like materials and processes for producing both
05/21/2003CN1419565A Chimeric Prostate-homing peptides with pro-apoptotic activity
05/21/2003CN1419564A Proteins comprising conserved regions of neisseria meningitidis surface antigen NhhA
05/21/2003CN1419563A Peptide derivative
05/21/2003CN1419456A Vaccine for the prophylactic or therapeutic immunization against HIV
05/21/2003CN1419413A Non-human transgenic animals expressing platelet-derived growth factor C (PDGF-C) and uses thereof
05/21/2003CN1418955A High temp. resistant FtsA protein gene and coded polypeptide and preparation process thereof
05/21/2003CN1418953A Specific expression of human leptin protein in egg white
05/21/2003CN1418890A Process for preparing momordic glucose-reducing polypeptide
05/21/2003CN1418889A Momordi glucose-reducing polypeptide
05/21/2003CN1109106C Hydroxyproline-rich proteins and pharmaceutical and cosmetic formulations containing them
05/21/2003CN1109047C Amphiapathic moleculs as cholesterol and other lipid uptake inhibitors
05/21/2003CN1109046C Induction of cytotoxic T-lymphocyte responses
05/21/2003CN1109045C Process for preparation of virus-inactivated factor VIII-contg. fraction by chromatographic methods
05/21/2003CN1109043C 角质形成细胞生长因子－2 Keratinocyte growth factor-2
05/21/2003CN1109041C Process for preparing substituted disulfide derivative and targeted form thereof
05/21/2003CN1109031C Bicycle-aromatic compound
05/21/2003CN1108814C Process for manufacture of pharmaceutical composition containing polyethylene glycol protein conjugates
05/20/2003US6566588 Plants transformed with a nucleic acid encoding the hypersensitive response associated protein amphipathetic protein-1
05/20/2003US6566586 Cotton expansin promoter sequence
05/20/2003US6566583 Schizochytrium PKS genes
05/20/2003US6566581 Animal model for use in the diagnosis and treatment of lung cancer
05/20/2003US6566580 Neurological disease model
05/20/2003US6566579 Generation of transgenic rodent; obtain embryonic stem cells, incubate with vector, transform cells, allow homologous recombination, propagate cells, recover animal, monitor gene expression
05/20/2003US6566513 Nucleotide sequences coding polypeptide for use as viricide
05/20/2003US6566504 Adding to the protein solution a cyclodextrin in an amount sufficient to form a stable complex with the protein, lyophilizing, recovering lyophilized protein/cyclodextrin complex, heating complex to inactivate viruses
05/20/2003US6566503 Mammalian CX3C chemokine
05/20/2003US6566502 Diagnosing mammary gland or colon and rectum cancer; obtain tissue sample, monitor preferential gene expression, compare to control, evaluate adjustments in gene expression, diagnos for cancer
05/20/2003US6566501 Polypeptide for use in the treatment of diabetes, cancer, cachexia, mammary gland cancer, viral, bacterial, malarial and asthma
05/20/2003US6566500 Compositions and methods for modifying toxic effects of proteinaceous compounds
05/20/2003US6566499 Adipocyte-specific protein homologs
05/20/2003US6566498 Proteins for use in the treatment of thrombosis and tumor metastisis
05/20/2003US6566497 Transport protein for use in human therapeutic and diagnostics
05/20/2003US6566496 Neurogenin
05/20/2003US6566492 Synthetic peptides of type II collagen for cartilage resorption assays
05/20/2003US6566491 Cyclopeptide derivatives
05/20/2003US6566490 Geenration of preferential microcrystals; obtain peptide solutions, homogenize under pressure, recover protein crystal
05/20/2003US6566489 Syndecan-4 binding protein (S4BP) and uses thereof
05/20/2003US6566343 High affinity nucleic acid ligands of complement system proteins
05/20/2003US6566332 OBG3 globular head and uses thereof for decreasing body mass
05/20/2003US6566328 Administering to the patient a therapeutically effective amount of a polypeptide for therapy of patient in need of agonist effect of human growth hormone
05/20/2003US6566325 And isolated nucleic acids containing coding regions of genes encoding such proteins; for use in gene therapy treatment of cancer, autoimmune diseases, viral diseases
05/20/2003US6566130 Androgen-regulated gene expressed in prostate tissue
05/20/2003US6566129 Transformed cells useful for the control of pests
05/20/2003US6566121 Genetically engineered microorganism for use as tools in the generation and expression of heterolgous proteins
05/20/2003US6566118 Generation of recombinant adeno- associated virus particles; generate nutrient broth, inoculate with genetically engineered cells, propagate cells and vector, release vector, harvest viral particles
05/20/2003US6566099 Nucleotide sequences coding polypeptide for use in the treatment of lysosomal storage disease
05/20/2003US6566098 DNA encoding truncated hepatocyte growth factor variants
05/20/2003US6566097 Polypeptide for use in the treatment of mammalian viral diseases
05/20/2003US6566096 Mammalian EDG-7 receptor homologs
05/20/2003US6566094 Nucleotide sequences coding polypeptide for use in the treatment of nervous system disorders
05/20/2003US6566092 Nucleotide sequences coding polypeptide for use in the treatment nervous system disorders
05/20/2003US6566091 Nucleotide sequences coding polypeptide for use in the treatment of nervous system disorders
05/20/2003US6566085 Synthetic peptides, antibodies directed against them, and the use thereof
05/20/2003US6566084 Detecting hydrolysis of cocaine compound; obtain cocaine mixture, incubate with antibody, monitor generation of benzoic zacid
05/20/2003US6566083 Detecion of preferential particles and activities in cells; obtain cells, transform, culture, express vector, measure the fluorescence of green fluorescent protein, evaluate gene activity
05/20/2003US6566082 T-cell antigens, and their use in diagnosis and treatment of T-cell mediated conditions
05/20/2003US6566080 Assay for and uses of peptide hormone receptor agonists
05/20/2003US6566078 36P6D5: secreted tumor antigen
05/20/2003US6566077 Qualitative or quantitative analysis of immunoglobulin; generate solid support, incubate with immunoglobulin mixture, wash microtiter plate, detect complexed immunoglobulin
05/20/2003US6566076 Detection and diagnosis of conditions associated with lung injury
05/20/2003US6566075 Methods for detecting human platelet-derived growth factor receptor agonists and antagonists
05/20/2003US6566074 Modulation of cell attachement; obtain cells, administering antibody that binds to a syndecan domain on cell surface, monitor cell attachment, evaluate cell for cancer
05/20/2003US6566073 Materials and methods involving conditional retention domains
05/20/2003US6566072 Diagnosing mammary gland cancer in humans; obtain tissue sample, recover proteins, incubate with antibody, detect presence bound antibody, amplified presence of boubd antibody indicates cancer
05/20/2003US6566066 Aquaporin-8 variant
1 ... 1603 1604 1605 1606 1607 1608 1609 1610 1611 1612 1613 1614 1615 1616 1617 1618 1619 1620 1621 1622 1623 ... 2916